Chemical
IFF sells botanical extracts, vitamins & minerals biz to SuanNutra in portfolio reshaping move
IFF CEO Erik Fyrwald said the divestiture will help the company sharpen its focus on its largest strategic priorities
-
By ICN Bureau | July 21, 2026
IFF is selling its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities to SuanNutra, a portfolio company of Carbyne Equity Partners, as the global ingredients giant continues to streamline its business around core growth areas.
The portfolio serves food, beverage, and nutrition markets worldwide with customized ingredient solutions and generated approximately $170 million in revenue in 2025. The deal covers operations across five manufacturing facilities in Europe, the United States, and Latin America, with about 600 employees included in the transaction.
IFF CEO Erik Fyrwald said the divestiture will help the company sharpen its focus on its largest strategic priorities.
“These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne,” said Erik Fyrwald, CEO IFF.
“This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health & Biosciences — where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders.”
The companies expect the transaction to close by the end of 2026, pending regulatory approvals, consultation requirements, and other customary closing conditions.
